Volume 5, Issue 7: Real-World HCV Care

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 5, Issue 7)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Discuss the real-world data to support the recommendation for eight vs 12 weeks treatment duration of sofosbuvir-ledipasvir.
  • Summarize current HCV treatment options for patients with advanced kidney disease for efficacy and safety.
  • Describe the risks and benefits of HCV therapies in HIV-HCV patients and older patients.
 
 

 

Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Course opens: 
08/31/2017
Course expires: 
08/30/2019
Cost:
$0.00
Andrew J. Muir, MD
Professor of Medicine and Chief, Division of Gastroenterology
Buke University School of Medicine
Durham, North Carolina
 
 

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance

Accreditation Period

Course opens: 
08/31/2017
Course expires: 
08/30/2019

Price

Cost:
$0.00
Please login or register to take this course.